Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.
about
Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Re-engineering a neuroprotecti ...... activity for use in dementia.
@ast
Re-engineering a neuroprotecti ...... activity for use in dementia.
@en
type
label
Re-engineering a neuroprotecti ...... activity for use in dementia.
@ast
Re-engineering a neuroprotecti ...... activity for use in dementia.
@en
prefLabel
Re-engineering a neuroprotecti ...... activity for use in dementia.
@ast
Re-engineering a neuroprotecti ...... activity for use in dementia.
@en
P2093
P2860
P1433
P1476
Re-engineering a neuroprotecti ...... activity for use in dementia.
@en
P2093
David R Pepperberg
Ehsan Tavassoli
Gregory R J Thatcher
Lawren VandeVrede
Manel Ben Aissa
Rezene T Asghodom
Sujeewa Piyankarage
P2860
P2888
P356
10.1186/S12868-015-0208-9
P577
2015-10-19T00:00:00Z
P5875
P6179
1046880121